0.2380USD-12.18%Mkt Cap: 10.33M USDP/E: —Last update: 2026-05-22
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and in…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap10.33M USD
Enterprise Value13.79M USD
Revenue (TTM)21.80K USD
Gross Profit17.57K USD
Net Income (TTM)-8.64M USD
Revenue/Share0.0010 USD
Last Price0.2380 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)4.51
PEG—
EV/EBITDA—
EV/Revenue632.82
P/S450.77
P/B-5.11
EPS (TTM)-0.26
EPS (Forward)0.06
52W Range
0.17202% of range3.330
52W High3.330 USD
52W Low0.1720 USD
Profitability
Gross Margin80.59%
Oper. Margin-12886.70%
EBITDA Margin0.00%
Profit Margin-39662.77%
ROE471.92%
ROA-155.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.41M USD
CapEx (TTM)—
FCF Margin-10621.16%
FCF Yield-22.42%
Net Debt1.53M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-2.90
Current Ratio0.65
Quick Ratio0.51
Book Value/Sh-0.0530 USD
Cash/Share0.1040 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.36.28M
Float16.59M
Insiders54.26%
Institutions5.34%
Short Interest
Short Ratio0.8d
Short % Float0.32%
Short % Out.0.19%
Shares Short68.14K
Short (prev mo.)126.92K
Technical
SMA 500.3712 (-35.9%)
SMA 2000.9527 (-75.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)10.76M
Avg Vol (10d)31.15M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—